Orion Corp (ORNBV) - Financial and Strategic SWOT Analysis Review

April 2021 | 67 pages | ID: O74F113070BEN
GlobalData

Abstracts

Orion Corp (ORNBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Orion Corp (Orion) develops, manufactures and markets human and veterinary pharmaceuticals, and active pharmaceutical ingredients (APIs). Its products include pharmaceuticals for the treatment of central nervous system disorders, cancer, and respiratory diseases. The company's pipeline encompasses investigational candidates for the treatment of amyotrophic lateral sclerosis, Parkinson’s disease, chronic obstructive pulmonary disease, and various cancer types. Orion’s client base consists of healthcare service providers and professionals, such as doctors, pharmacies, veterinarians, hospitals, healthcare centers, clinics and laboratories. The company sells its products in European markets through own sales network and in international markets through several partners and distributors. Orion is headquartered in Espoo, Finland.

Orion Corp Key Recent Developments

Apr 21,2021: LED lighting, controls provider Orion secures $16.4M in follow-on national account orders, underscoring outlook for approximately 30% revenue growth in FY 2022
Apr 12,2021: Orion publishes Interim Report for January–March 2021 on Tuesday 27 April 2021
Mar 25,2021: Decisions taken by Orion Annual General Meeting on 25 March 2021
Feb 09,2021: Orion Group financial statement release for 2020
Nov 10,2020: Orion invests EUR 17 million in its production plants in Turku

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Orion Corp - Key Facts
Orion Corp - Key Employees
Orion Corp - Key Employee Biographies
Orion Corp - Major Products and Services
Orion Corp - History
Orion Corp - Company Statement
Orion Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Orion Corp - Business Description
Product Category: Animal Health
Overview
Performance
Product Category: Fermion and Contract Manufacturing
Overview
Performance
Product Category: Other
Performance
Product Category: Proprietary Products
Overview
Performance
Product Category: Specialty Products
Overview
Performance
Geographical Segment: Finland
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other Countries
Performance
Geographical Segment: Other Europe
Performance
Geographical Segment: Scandinavia
Performance
Orion Corp - Corporate Strategy
Orion Corp - SWOT Analysis
SWOT Analysis - Overview
Orion Corp - Strengths
Orion Corp - Weaknesses
Orion Corp - Opportunities
Orion Corp - Threats
Orion Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Orion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Orion Corp, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 21, 2021: LED lighting, controls provider Orion secures $16.4M in follow-on national account orders, underscoring outlook for approximately 30% revenue growth in FY 2022
Apr 12, 2021: Orion publishes Interim Report for January–March 2021 on Tuesday 27 April 2021
Mar 25, 2021: Decisions taken by Orion Annual General Meeting on 25 March 2021
Feb 09, 2021: Orion Group financial statement release for 2020
Nov 10, 2020: Orion invests EUR 17 million in its production plants in Turku
Oct 21, 2020: Orion Group interim report 1-9/2020
Oct 19, 2020: Orion upgrades full-year outlook for 2020 provided on 19 October 2020
Sep 10, 2020: Orion is planning to renew its R&D strategy and organisation
Jul 17, 2020: Orion Group half-year financial report 1-6/2020
Jul 08, 2020: Orion upgrades full-year outlook for 2020

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Orion Corp, Key Facts
Orion Corp, Key Employees
Orion Corp, Key Employee Biographies
Orion Corp, Major Products and Services
Orion Corp, History
Orion Corp, Subsidiaries
Orion Corp, Key Competitors
Orion Corp, Ratios based on current share price
Orion Corp, Annual Ratios
Orion Corp, Annual Ratios (Cont...1)
Orion Corp, Annual Ratios (Cont...2)
Orion Corp, Interim Ratios
Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Orion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Orion Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Orion Corp, Performance Chart (2016 - 2020)
Orion Corp, Ratio Charts
Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Orion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021